sulforaphane has been researched along with Alveolitis, Fibrosing in 5 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease with no effective treatment." | 5.48 | Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition. ( Jeong, SH; Kim, DY; Kim, YJ; Kyung, SY; Park, JW; Son, ES; Yoon, JY, 2018) |
| "Pulmonary fibrosis was induced in C57/BL6 mice by intratracheal instillation of BLM." | 5.46 | Sulforaphane prevents bleomycin‑induced pulmonary fibrosis in mice by inhibiting oxidative stress via nuclear factor erythroid 2‑related factor‑2 activation. ( Hu, Y; Ma, T; Ma, Z; Rong, G; Shi, S; Yan, B; Yang, J, 2017) |
| "Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease with no effective treatment." | 1.48 | Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition. ( Jeong, SH; Kim, DY; Kim, YJ; Kyung, SY; Park, JW; Son, ES; Yoon, JY, 2018) |
| "Pulmonary fibrosis was induced in C57/BL6 mice by intratracheal instillation of BLM." | 1.46 | Sulforaphane prevents bleomycin‑induced pulmonary fibrosis in mice by inhibiting oxidative stress via nuclear factor erythroid 2‑related factor‑2 activation. ( Hu, Y; Ma, T; Ma, Z; Rong, G; Shi, S; Yan, B; Yang, J, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yan, B | 1 |
| Ma, Z | 1 |
| Shi, S | 1 |
| Hu, Y | 1 |
| Ma, T | 1 |
| Rong, G | 1 |
| Yang, J | 1 |
| Zhang, Z | 2 |
| Qu, J | 2 |
| Zheng, C | 2 |
| Zhang, P | 2 |
| Zhou, W | 2 |
| Cui, W | 2 |
| Mo, X | 1 |
| Li, L | 1 |
| Xu, L | 2 |
| Gao, J | 2 |
| Kyung, SY | 1 |
| Kim, DY | 1 |
| Yoon, JY | 1 |
| Son, ES | 1 |
| Kim, YJ | 1 |
| Park, JW | 1 |
| Jeong, SH | 1 |
| Pekovic-Vaughan, V | 1 |
| Gibbs, J | 1 |
| Yoshitane, H | 1 |
| Yang, N | 1 |
| Pathiranage, D | 1 |
| Guo, B | 1 |
| Sagami, A | 1 |
| Taguchi, K | 1 |
| Bechtold, D | 1 |
| Loudon, A | 1 |
| Yamamoto, M | 1 |
| Chan, J | 1 |
| van der Horst, GT | 1 |
| Fukada, Y | 1 |
| Meng, QJ | 1 |
5 other studies available for sulforaphane and Alveolitis, Fibrosing
| Article | Year |
|---|---|
Sulforaphane prevents bleomycin‑induced pulmonary fibrosis in mice by inhibiting oxidative stress via nuclear factor erythroid 2‑related factor‑2 activation.
Topics: Alveolar Epithelial Cells; Animals; Apoptosis; Bleomycin; Disease Models, Animal; Gene Expression; I | 2017 |
Nrf2 antioxidant pathway suppresses Numb-mediated epithelial-mesenchymal transition during pulmonary fibrosis.
Topics: Animals; Antioxidants; Bleomycin; Cell Line; Disease Models, Animal; Down-Regulation; Epithelial-Mes | 2018 |
Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
Topics: Animals; Bleomycin; Cell Line; Collagen Type I; Collagen Type IV; Epithelial-Mesenchymal Transition; | 2018 |
Downregulation of HMGB1 is required for the protective role of Nrf2 in EMT-mediated PF.
Topics: Animals; Cell Line; Down-Regulation; Epithelial-Mesenchymal Transition; Gene Expression Regulation; | 2019 |
The circadian clock regulates rhythmic activation of the NRF2/glutathione-mediated antioxidant defense pathway to modulate pulmonary fibrosis.
Topics: Animals; Anticarcinogenic Agents; Bleomycin; Circadian Clocks; E-Box Elements; Female; Gene Expressi | 2014 |